Replies to post #18592 on The Rising Influence of Rising Affluence

[DewDiligence]

I would not invest in BYND as they lose money and Tyson sold their stake in Beyond Meat is not a good sign.

I concur with respect to BYND’s outsized valuation for a money-losing business; however, I don’t consider TSN’s divestiture a concern for the reason mentioned in #msg-148559069.

[DewDiligence]

I don't understand the rash of IPOs of companies losing money like Uber, Lyft, Beyond Meat. The worst of all is the filing of WeWork, losing 1.9B on revenue of 1.8B.

For investors (as opposed to traders), these IPOs are a scary sight.

Biotech IPOs now look better.

Biotech IPOs vary greatly in terms of development stage, business plan, and financial strength, so it’s hard to generalize.